The human gut microbiome plays a vital role in maintaining health. Disruption of this ecosystem, or dysbiosis, is linked not only to gastrointestinal disorders such as inflammatory bowel disease, but also to systemic conditions including obesity, type 2 diabetes, atopy, and neurodegenerative diseases. Antibiotics are a major contributor to dysbiosis, depleting beneficial bacteria, reducing microbial diversity, and promoting the proliferation of opportunistic and antimicrobial-resistant pathogens. Probiotics have demonstrated efficacy in reducing antibiotic-associated diarrhoea. Probitec®, containing 15 billion CFUs of Lactobacillus acidophilus La-14, offers targeted support for restoring microbial balance and addressing antibiotic-associated dysbiosis.